Visit Fairbanks at ENDO 2020 (Updated)

UPDATE 3/11/20: the Endocrine Society has canceled ENDO 2020. Dr Schneyer’s abstract will be published by the Journal of the Endocrine Society; we will publish a link later in the spring when it is available.

If you’re attending this year’s Endocrine Society meeting in San Francisco, be sure to visit with Fairbanks CEO Dr. Alan Schneyer on March 30 at 9:15 AM at the “Entrepreneurship and Industry in Endocrinology” symposium promoting and discussing the entrepreneurial career path for society members.  Dr Schneyer will address topics including starting a company to develop a new endocrine-related therapy or technology and funding the company through various stages.  The session will be followed by a networking opportunity for additional contact with the speakers. 

As highlighted recently in Endocrine News, Dr Schneyer has been promoting entrepreneurism in discussion with trainees at numerous institutions about careers in science.  Part of this advocacy has been focused on creating an entrepreneurial track at professional scientific meetings such as the Endocrine Society in which he has been a member for his entire career. 

At ENDO 2019, Dr Schneyer participated in a well-attended symposium highlighting three Endocrine Society members who have started companies and were at distinct phases of therapy development and commercialization. 

On March 29th at 11:00 Dr. Schneyer will also present research and development progress at Fairbanks in developing a novel therapy for diabetes.  March will be an exciting time for Fairbanks, stay tuned for more details!